Cargando…
Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities
BACKGROUND: Chordoma is a slow-growing but malignant subtype of bone sarcoma with relatively high recurrence rates and high resistance to chemotherapy. It is urgent to understand the underlying regulatory networks to determine more effective potential targets. Phosphorylative regulation is currently...
Autores principales: | Hang, Jing, Ouyang, Hanqiang, Wei, Feng, Zhong, Qihang, Yuan, Wanqiong, Jiang, Liang, Liu, Zhongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563620/ https://www.ncbi.nlm.nih.gov/pubmed/36248973 http://dx.doi.org/10.3389/fonc.2022.941046 |
Ejemplares similares
-
CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021) -
Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data
por: Zhong, Qihang, et al.
Publicado: (2021) -
Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer
por: Yang, Ganglong, et al.
Publicado: (2023) -
Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases
por: Selvan, Lakshmi Dhevi Nagarajha, et al.
Publicado: (2018) -
Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese Patients
por: Pan, Lulu, et al.
Publicado: (2020)